Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Exscientia is an AI-driven pharmatech company dedicated to discovering, designing, and developing the best possible drugs in the fastest and most effective manner. By fusing an end-to-end AI-native platform with the deep expertise of its seasoned drug hunters, Exscientia aims to bring life-changing medicines to patients more efficiently. Their innovative approach integrates AI and automation across the entire drug discovery process, from target identification to patient selection, with a focus on precision medicine.
Serves as the global headquarters, housing primary R&D laboratories, AI development teams, and corporate leadership, driving the company's mission to revolutionize drug discovery.
Located in the prestigious Oxford Science Park, featuring advanced, purpose-built laboratories and collaborative workspaces designed to foster innovation in AI and bioscience.
A dynamic and mission-driven environment characterized by scientific rigor, interdisciplinary collaboration between AI experts and drug developers, and a strong focus on innovation to accelerate medical breakthroughs. Employees often describe it as fast-paced and intellectually stimulating.
The Oxford HQ is central to Exscientia's global strategy, leveraging the UK's strong life sciences ecosystem, access to world-class talent, and proximity to leading academic institutions to pioneer AI-driven drug discovery and development.
Exscientia supports its global operations through a network of offices and laboratories strategically located in key innovation hubs across Europe (UK, Austria), North America (USA), and Asia (Japan). This international footprint enables the company to access diverse talent pools, engage with regional scientific and business ecosystems, and advance its AI-driven drug discovery and development programs on a global scale. Functions supported globally include AI platform development, experimental biosciences, clinical development, business development, and strategic partnerships, facilitating a 24/7 approach to innovation.
The Schrödinger Building, Oxford Science Park, Heatley Road
Oxford
Oxfordshire
United Kingdom
Address: Hochstrasengasse 48, 1130 Vienna, Austria
Leverages Vienna's growing tech talent pool and central European location to support global technology development and innovation in AI for drug discovery.
Address: Dundee One, Unit 5, River Court, 5 West Victoria Dock Road, Dundee DD1 3JT, UK
Benefits from Dundee's strong academic life sciences research and expertise in drug discovery, contributing critical experimental data to Exscientia's integrated R&D platform.
Address: 701 Brickell Avenue, Suite 1550, Miami, FL 33131, USA
Facilitates engagement with the North American pharmaceutical industry, research institutions, and financial markets, driving growth, collaborations, and strategic initiatives.
Address: One Broadway, 14th Floor, Cambridge, MA 02142, USA
Taps into one of the world's leading biotechnology clusters, fostering collaborations with top academic institutions and industry partners to advance AI in medicine and expand research capabilities.
Address: Life Science Hub West Japan, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan
Establishes Exscientia's presence in a leading global pharmaceutical market, enabling access to regional innovation, talent, patient data diversity, and partnership opportunities in the APAC region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Exscientia' leadership includes:
Exscientia has been backed by several prominent investors over the years, including:
Exscientia has strategically strengthened its executive leadership over the past 12 months with key appointments in scientific and medical roles to accelerate its AI-driven drug discovery and development pipeline. In early 2024, the company also announced a broader organizational restructuring to streamline operations and prioritize internal asset development, which may have impacted overall leadership structure, though specific executive departures beyond announced hires were not detailed individually.
Discover the tools Exscientia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Exscientia primarily uses the email format [first].[last]@exscientia.ai. This is a common structure for professional communication within the company. Understanding this format can be helpful for legitimate outreach to company representatives.
[first].[last]@exscientia.ai
Format
jane.doe@exscientia.ai
Example
75%
Success rate
Exscientia plc / GlobeNewswire • May 9, 2024
Exscientia reported its Q1 2024 financial results, highlighting progress in its pipeline, strategic collaborations, and operational efficiencies following its recent restructuring. The company confirmed its cash runway extends into 2027....more
Exscientia plc / GlobeNewswire • April 8, 2024
Exscientia presented new data at the American Association for Cancer Research (AACR) Annual Meeting 2024, demonstrating the capabilities of its AI platform in discovering and developing novel oncology therapies and patient selection strategies....more
Exscientia plc / GlobeNewswire • February 1, 2024
Exscientia announced a strategic restructuring plan to focus its resources on advancing its internal oncology pipeline, optimize its operational model, and extend its cash runway. The plan included a refinement of its R&D focus and a reduction in workforce....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Exscientia, are just a search away.